We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 30 JANUARY 2018
Federal Circuit Emphasizes Need For Reasonable Expectation Of Success
Foley & Lardner LLP
In Genzyme Corp. v. Dr. Reddy's Labs. Ltd., the Federal Circuit affirmed the district court decision upholding Genzyme's Orange Book listed patent for the cancer drug Mozobil® against an obviousness challenge, because the asserted prior art references failed to provide a reasonable expectation of success.
United StatesIntellectual Property










